CBAY
- · NASDAQ
- Sector -
- Industry -
- Website cymabay.com
- Employees(FY) 60
- ISIN -
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: CBAY
Overview
In this investment analysis report, we will delve into the financial statements of CBAY, a company operating in the Health Technology sector within the Biotechnology industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow...
Technical Analysis of CBAY 2024-03-15
Overview:
In analyzing the technical indicators for CBAY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Indicators...
Recent News & Updates
- 2024-03-22 09:18
- 2024-03-21 21:18
- 2024-03-11 14:23
- 2024-03-04 08:00
- 2024-03-03 19:00
- 2024-02-28 18:10
- 2024-02-28 16:45
- 2024-02-28 03:45
- 2024-02-21 17:43
- 2024-02-21 04:43
- 2024-02-20 16:05
- 2024-02-20 03:05
- 2024-02-15 08:28
- 2024-02-15 03:01
- 2024-02-13 09:24
- 2024-02-12 12:34
Trimble, CymaBay Therapy rise; Big Lots, Monday.com fall, Monday, 2/12/2024(Associated Press Finance)
- 2024-02-12 12:27
Stocks to Watch Monday: Diamondback, CymaBay, Gilead, Tod's(The Wall Street Journal)
- 2024-02-12 12:03
Why Wall Street Was Lukewarm on Gilead’s $4.3 Billion Liver-Drug Deal(The Wall Street Journal)
- 2024-02-12 10:57
CymaBay Rockets After Gilead Snaps Up The Liver-Focused Biotech For $4.3 Billion(Investor's Business Daily)
- 2024-02-12 09:57
- 2024-02-12 09:45
CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal(The Wall Street Journal)
- 2024-02-12 08:45
- 2024-02-12 08:42
- 2024-02-12 08:38
- 2024-02-12 08:33
- 2024-02-12 00:43
- 2024-02-12 00:27
- 2024-02-11 20:18
- 2024-02-11 19:45
- 2024-02-11 19:44
Gilead Sciences to Buy CymaBay Therapeutics for $4.3 Billion(Yahoo Finance)